NP BALANCE - Ann Intern Med, 2009 - the-aps.org Humans are intermittently exposed to large variations in potassium intake, which
range from periods of fasting to ingestion of potassium- rich meals. These
fluctuations would abruptly alter plasma po- tassium concentration if not ... Cited by 2 - Related articles - View as HTML - All 9 versions
A Khanna, WB White - The American Journal of Medicine, 2009 - Elsevier The development of hyperkalemia is common in patients with cardiac and kidney
disease who are administered drugs that antagonize the
renin-angiotensin-aldosterone system (RAAS). As the results of large-scale ... Cited by 3 - Related articles - All 19 versions
V Savica, LA Calo, P Monardo, PA Davis, A … - Journal of the American Society of Nephrology, 2009 - asn-online.org ABSTRACT In uremic patients, hyperphosphatemia is associated with cardiovascular
calcification and increased cardiovascular mortality. Despite the use of
phosphate binders, only half of hemodialysis (HD) patients achieve ... Cited by 4 - Related articles - View as HTML - All 8 versions
L Masi, A Gozzini, A Franchi, D Campanacci, A … - The Journal of Bone and Joint Surgery, 2009 - JBJS Background: Tumoral calcinosis is a rare disease characterized by
hyperphosphatemia due to hypophosphaturia and by ectopic calcifications.
Phosphatonins are important hormones that regulate phosphorus homeostasis. ... Cited by 4 - Related articles - All 2 versions
- ►physiology.org Y Zhang, DH Lin, ZJ Wang, Y Jin, B Yang, … - American Journal of Physiology- Cell Physiology, 2008 - Am Physiological Soc We used Western blot analysis to examine the effect of dietary K intake on the
expression of serine/threonine protein phosphatase in the kidney. K restriction
significantly decreased the expression of catalytic subunit of protein ... Cited by 3 - Related articles - BL Direct - All 5 versions
P San-Cristobal, P de los Heros, J Ponce- … - Am J Nephrol, 2008 - content.karger.com Two members of a recently discovered family of protein kinases are the cause of
an inherited disease known as pseudohypoaldosteronism type II (PHAII). These
patients exhibit arterial hypertension together with hyperkalemia and ... Cited by 3 - Related articles - All 4 versions
